Journal
CYTOTHERAPY
Volume 13, Issue 6, Pages 767-768Publisher
INFORMA HEALTHCARE
DOI: 10.3109/14653249.2011.563295
Keywords
cancer immunotherapy; ex vivo expansion; good manufacturing practice; natural killer cells